Prescription Bottle Cap with Nasal Naloxone Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Opioid overdoses pose a significant risk due to limited access to effective countermeasures, often resulting in unnecessary fatalities, as opioid prescriptions are commonly filled without identifying potential addiction issues in patients.

Innovation Solution

A prescription bottle cap equipped with a delivery element capable of nasal administration of opioid overdose reversal agents, such as naloxone, to facilitate prompt and effective response to opioid overdoses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If opioid prescriptions are commonly filled without identifying potential addiction issues, then accessibility to opioid treatment is improved, but the risk of overdose increases

Engineering Contradiction:
Improveaccessibility to opioid treatmentVSAvoidrisk of overdose
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent incorporates the overdose reversal agent (naloxone) into the prescription bottle cap before the patient receives the opioid medication. This preliminary action ensures that the countermeasure is already available and accessible to the patient at home, eliminating the need to wait for emergency medical personnel who may not arrive in time. The reversal agent is prepared in advance and made easily accessible through the cap mechanism.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The prescription bottle cap serves as an intermediary device that bridges the gap between the opioid medication and the overdose reversal agent. The cap contains the naloxone and provides a delivery mechanism (nasal spray, oral dissolvable strip, or inhalable powder) that enables the patient or bystanders to administer the countermeasure immediately at the scene of an overdose, without requiring emergency medical personnel or specialized medical facilities.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If opioid overdose reversal agents are limited to emergency medical personnel, then professional control is maintained, but accessibility and response time are reduced

Engineering Contradiction:
Improveprofessional controlVSAvoidresponse time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent empowers patients and their families to self-administer the overdose reversal agent through the prescription bottle cap mechanism. The system is designed to be simple and intuitive, requiring no specialized medical training. The patient or any bystander can immediately respond to an overdose by using the naloxone delivered through the cap, eliminating the delay associated with waiting for emergency medical personnel to arrive and administer treatment.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The reversal agent is prepared and made accessible in advance through the prescription bottle cap, before any overdose occurs. This preliminary preparation ensures that the countermeasure is immediately available when needed, rather than requiring emergency medical personnel to bring or prepare the treatment upon arrival. The cap contains pre-measured doses ready for immediate administration.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If a delivery element is integrated into the prescription bottle cap, then accessibility to reversal agents is improved, but device complexity increases

Engineering Contradiction:
Improveaccessibility to reversal agentsVSAvoidcap structure
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The prescription bottle cap is designed to perform multiple functions: it serves as the traditional closure for the prescription bottle and simultaneously houses the overdose reversal agent with a delivery mechanism. The cap can deliver the naloxone through multiple routes (nasal spray, oral dissolvable strip, or inhalable powder) depending on the specific embodiment. This multi-functionality integrates the reversal agent delivery system into the existing cap structure without requiring a completely separate device.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The overdose reversal agent and its delivery mechanism are nested within the prescription bottle cap structure. The cap contains compartments or reservoirs that hold the naloxone in various forms (liquid for nasal spray, solid for oral dissolvable strip, or powder for inhalation). This nesting approach allows the complex delivery system to be compactly integrated into the familiar cap form factor, maintaining ease of use while providing advanced functionality.

Inventive Principle:
Principle #7Nested doll (Nesting)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The cap enables secure storage and selective administration of opioid reversal agents directly from the prescription bottle cap, enhancing accessibility and response to opioid overdoses, potentially reducing fatalities by providing a countermeasure directly to individuals in need.

Implementation Method 1

The pump may be capable of forcing the substance from the reservoir, through the nozzle, and out of the nozzle

Methodology Applied
Scientific EffectPump: Pump

Implementation Method 2

The nozzle may be capable of delivering the substance to an individual in a desired manner (e.g., by creating a fine mist from a liquid substance for nasal administration)

Methodology Applied
Scientific EffectAerosol: Aerosol

Data Source

PatentUS10933204B2Prescription bottle cap capable of administering opioid overdose reversal agent
Publication Date: 2021.03.02 COUNTERACT LLC
  • US10933204B2 patent drawing
  • US10933204B2 patent drawing
  • US10933204B2 patent drawing

AI summary

An apparatus for delivering a therapeutic agent may be associated with a cap for a bottle that contains a prescription for a drug to which the therapeutic agent corresponds. When the prescription bottle holds an opioid, the therapeutic agent may be a substance that counteracts the effects of the opioid. The apparatus may include a nozzle that facilitates nasal administration of the therapeutic agent. The apparatus may be capable of attaching to a cap for a prescription bottle, or the apparatus may have a configuration that enables it to serve as the cap for the prescription bottle.